Natriumoxibat Reig Jofre (Sodium Oxybate)

Sodium Oxybate, the active ingredient in Natriumoxibat Reig Jofre, is a Gamma‑hydroxybutyrate (GHB) analog presented as an oral formulation for oral use. It is indicated for the treatment of narcolepsy with cataplexy and excessive daytime sleepiness in adult patients.

GNH USA supplies Natriumoxibat Reig Jofre as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across markets.

Sodium Oxybate is used in the management of sleep‑wake disorders, particularly narcolepsy.

- Narcolepsy with cataplexy: reduces the frequency and severity of cataplexy episodes. - Excessive daytime sleepiness: improves wakefulness and lessens daytime sleepiness. - Narcolepsy (overall): consolidates nighttime sleep architecture, leading to better daytime alertness.

Adverse reactions may occur with sodium oxybate therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Enuresis: nighttime urinary incontinence. - Insomnia: difficulty initiating sleep. - Irritability: mood changes or agitation.

Serious or Rare Side Effects: - Respiratory depression: reduced breathing effort, potentially life‑threatening. - Seizures: rare occurrence of convulsive episodes. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, swelling, or anaphylaxis. - Abuse potential: risk of dependence with misuse.

Sodium oxybate requires careful patient assessment and monitoring.

- Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown excretion; consider potential infant exposure. - Renal impairment: dose may need adjustment; monitor renal function. - Alcohol use: contraindicated due to additive CNS depression. - Driving or operating machinery: avoid until individual response is known. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Sodium oxybate can interact with several drug classes.

Major Interactions (Avoid): - Alcohol: additive central nervous system depression. - Other CNS depressants (e.g., benzodiazepines, opioids): risk of severe respiratory depression. - Additional GHB‑containing products: potential overdose and profound sedation.

Moderate Interactions (Monitor Closely): - Monoamine oxidase inhibitors (MAOIs): may amplify CNS effects. - Antihypertensive agents: possible enhancement of hypotensive response. - Anticonvulsants: may alter seizure threshold or drug levels.